Pigmentary disorders

Depigmentation therapy refers to medical treatments that remove skin pigmentation. Depigmentation therapy is used in someone that has widespread, but incomplete, vitiligo on the face and/or other sites, in an attempt to improve their appearance. The most commonly used depigmenting agent is monobenzyl ether of hydroquinone (MBEH). If the patient cannot tolerate MBEH, or if treatment fails, combination therapies or other treatments may be considered. Depigmentation therapy may be considered in the management of treatment resistant vitiligoaffecting more than 50% of the body surface area or affecting cosmetically sensitive, exposed body sites.

  • Melanocyte biology
  • Vitiligo
  • Disorders of hyper pigmentation

Related Conference of Pigmentary disorders

Pigmentary disorders Conference Speakers